Developing sensors to detect diseases early

Ratiometric Metabolite Sensors for the Early Detection of Disease

NIH-funded research Montana State University - Bozeman · NIH-11021356

This study is working on new colorful dyes and proteins that can help doctors spot signs of diseases like Alzheimer's more quickly, so they can diagnose and manage patients better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMontana State University - Bozeman NIH-funded
Lab location1 site (Bozeman, United States)
Project IDNIH-11021356 on NIH RePORTER

What this research studies

This research focuses on creating innovative fluorescent dyes and proteins that can help detect disease-related metabolites in real-time. By using advanced imaging techniques, the team aims to improve the understanding of various diseases, particularly Alzheimer's disease, through the development of novel biosensors. The project involves synthesizing new fluorescent compounds and studying specific proteins associated with disease processes, which could lead to earlier diagnosis and better patient management.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with conditions unrelated to metabolic changes or those not at risk for Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection of diseases like Alzheimer's, improving treatment outcomes for patients.

How similar studies have performed: Other research has shown promise in using fluorescent sensors for disease detection, indicating that this approach could be effective.

Where this research is happening

Bozeman, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.